Drug Shortage Report for 20% PROSOL
| Report ID | 132584 |
| Drug Identification Number | 02141450 |
| Brand name | 20% PROSOL |
| Common or Proper name | Amino Acid Injection 20% w/v |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | VALINE LYSINE HISTIDINE ISOLEUCINE LEUCINE PHENYLALANINE THREONINE DL-METHIONINE TRYPTOPHAN ALANINE GLYCINE ARGININE PROLINE GLUTAMIC ACID SERINE L-ASPARTIC ACID TYROSINE |
| Strength(s) | 1.44G 1.35G 1.18G 1.08G 1.08G 1G 0.98G 0.76G 0.32G 2.76G 2.06G 1.96G 1.34G 1.02G 1.02G 0.6G 0.05G |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 2L bag (4bags/case) (JB6186) |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2021-01-28 |
| Actual start date | 2021-01-28 |
| Estimated end date | 2021-03-01 |
| Actual end date | 2021-03-01 |
| Shortage status | Resolved |
| Updated date | 2021-03-02 |
| Company comments | Baxter Product Code JB6186. Product has been placed on allocation at 50% of historical usage. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-03-02 | English | Compare |
| v5 | 2021-03-01 | French | Compare |
| v4 | 2021-03-01 | English | Compare |
| v3 | 2021-01-29 | English | Compare |
| v2 | 2021-01-28 | French | Compare |
| v1 | 2021-01-28 | English | Compare |
Showing 1 to 6 of 6